Doctors are worried about the fact that prostate cancer affects more men every year throughout the United States. The statistics showed that the number of diagnoses has increased by a staggering 72 percent over the last decade.
Some believe that this situation originates from the fact that just a low number of men are screened to establish whether they have the disease or not.
According to Dr. Edward Schaeffer, urology chairperson at Northwestern University Feinberg School of Medicine and Northwestern Medicine, there are two speculations regarding the high number of prostate cancer cases.
One of them would be that the disease is more aggressive now than ever, even if men are being screened or not, and the other speculation is that screening guidelines are not efficient enough because most men receive the diagnose when the cancer is already in advanced stages.
Scientists have not solved this puzzle yet, but they will continue their investigation to gather more information. The team reviewed the National Cancer Data Base and found out that over 767,000 men from 1,089 medical facilities throughout the United States received a prostate cancer diagnose between 2004 and 2013.
Out of the total cases, only three percent of the patients suffered from metastatic prostate cancer, meaning that cancer had already been spread. Based on the information, men between 55 and 69 years made up for the highest part of the patients.
The worst part is that between 2004 and 2013 the number of cases has increased by 92 percent from 702 to 1,345 cases. Also, the metastatic prostate cancer statistics showed that between 2004 and 2013 the number of cases increased from 1,685 cases to 2,890.
The United States Preventive Services Task Force issued a recommendation in 2012 that PSA routine tests that could detect prostate cancer should no longer be made. Schaeffer underlined that the situation from 2013, when so many men were diagnosed with metastatic cancer, proved that this disease is very aggressive, and it must be tackled.
He also strongly believes that rectal exams and PSA screening are the most efficient ways of establishing an early diagnosis. According to Dr. Eric Klein, Glickman Urological & Kidney Institute chairperson from Cleveland Clinic, the recommendation from 2012 against PSA screening led to severe consequences as the number of prostate cancer cases experienced a staggering increase.